Recombinant Human DNM1L 293 Cell Lysate

• Cat.No.: DNM1L-6859HCL

Specification

• Description: Antigen standard for dynamin 1-like (DNM1L), transcript variant 1 is a lysate prepared from HEK293T cells transiently transfected with a TrueORF gene-carrying pCMV plasmid and then lysed in RIPA Buffer. Protein concentration was determined using a colorimetric assay. The antigen control carries a C-terminal Myc/DDK tag for detection.
• Source: HEK 293 cells
• Species: Human
• Components: This product includes 3 vials: 1 vial of gene-specific cell lysate, 1 vial of control vector cell lysate, and 1 vial of loading buffer. Each lysate vial contains 0.1 mg lysate in 0.1 ml (1 mg/ml) of RIPA Buffer (50 mM Tris-HCl pH7.5, 250 mM NaCl, 5 mM EDTA, 50 mM NaF, 1% NP40). The loading buffer vial contains 0.5 ml 2X SDS Loading Buffer (125 mM Tris-Cl, pH6.8, 10% glycerol, 4% SDS, 0.002% Bromophenol blue, 5% beta-mercaptoethanol).
• Size: 0.1 mg
• Storage Instruction: Store at -80°C. Minimize freeze-thaw cycles. After addition of 2X SDS Loading Buffer, the lysates can be stored at -20°C. Product is guaranteed 6 months from the date of shipment.
• Applications: ELISA, WB, IP. WB: Mix equal volume of lysates with 2X SDS Loading Buffer. Boil the mixture for 10 min before loading (for membrane protein lysates, incubate the mixture at room temperature for 30 min). Load 5 ug lysate per lane.

Gene Information

• Gene Name: DNM1L dynamin 1-like [ Homo sapiens ]
• Official Symbol: DNM1L
• Synonyms: DNM1L; dynamin 1-like; dynamin-1-like protein; DRP1; DVLP; DYMPLE; HDYNIV; VPS1; dynamin-like protein 4; dynamin-like protein IV; Dnm1p/Vps1p-like protein; dynamin-related protein 1; dynamin family member proline-rich carboxyl-terminal domain less; DLP1; EMPF; DYNIV-11; FLJ41912
• Gene ID: 10059
• mRNA Refseq: NM_012062
• Protein Refseq: NP_036192
• MIM: 603850
• UniProt ID: O00429
• Chromosome Location: 12p11.21
• Pathway: Apoptosis, organism-specific biosystem; Apoptotic executionphase, organism-specific biosystem; Bacterial invasion of epithelial cells, organism-specific biosystem; Bacterial invasion of epithelial cells, conserved biosystem; Endocrine and other factor-regulated calcium reabsorption, organism-specific biosystem; Endocrine and other factor-regulated calcium reabsorption, conserved biosystem; Endocytosis, organism-specific biosystem
• Function: GTP binding; GTPase activity; hydrolase activity; identical protein binding; nucleotide binding; protein binding; ubiquitin protein ligase binding

Reviews

12/10/2020

Increase yield and purity and improve production efficiency in biotechnology production.

10/22/2019

Good fluorescence labeling performance in light microscopy technology, which is helpful for cell imaging studies.

06/18/2019

In vaccine research, it has been found that it can induce immune protective effect and has potential for disease prevention.

Q&As

Does a mutation in the DNM1L gene cause a genetic predisposition?

A mutation in the DNM1L gene may have a genetic predisposition, meaning that the mutation is more likely to occur in a patient's family member.

What is the relationship between DNM1L and neuronal connectivity and synaptic function?

DNM1L is involved in the regulation of neuronal connections and synaptic function, especially in the endocytosis and release process of synaptic vesicles, thereby affecting the transmission of neural signals.

What is the inheritance pattern of DNM1L gene mutations?

DNM1L gene mutations can be transmitted in different genetic ways such as autosomal dominant, dominant negative, and dominant homosexual, depending on the type and location of the mutation.

Which diseases are DNM1L gene mutations associated with?

DNM1L gene mutations are associated with a number of neurological-related diseases, including Charcot-Marie-Tooth disease, multiple system atrophy, intellectual disability, and movement disorders.

What is the relationship between DNM1L gene mutations and neurodegenerative diseases?

Mutations in the DNM1L gene may be associated with neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease and Huntington's disease.

How to assess the impact of DNM1L gene mutations on disease prognosis?

Through long-term follow-up and clinical data analysis of patients, the impact of DNM1L gene mutations on disease prognosis, such as age of onset, disease progression and quality of life, can be evaluated.